Drug Shortage Report for THYMOGLOBULIN

Last updated on 2019-03-22 History
Report ID 73721
Drug Identification Number 02246805
Brand name THYMOGLOBULIN
Common or Proper name Thymoglobulin
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ANTI-THYMOCYTE GLOBULIN
Strength(s) 25MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 X 10ml
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-04-01
Actual start date
Estimated end date 2019-04-15
Actual end date 2019-03-20
Shortage status Avoided shortage
Updated date 2019-03-22
Company comments Delay in Supply (Potential Back Order) - All efforts are being made to resolve these issues and avoid an out of stock situation. As a result, we will be allocating purchasing of Thymoglobulin based on each accounts historical sales data. Any updates will be communicated on the www.drugshortagescanada.ca website.
Health Canada comments
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-03-22 French Compare
v7 2019-03-22 English Compare
v6 2019-01-29 French Compare
v5 2019-01-29 English Compare
v4 2019-01-29 French Compare
v3 2019-01-29 English Compare
v2 2019-01-28 French Compare
v1 2019-01-28 English Compare